Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $16 | $75 | $54 | $42 |
| Short-Term Investments | $82 | $56 | $88 | $100 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $0 |
| Total Curr. Assets | $99 | $131 | $143 | $143 |
| Property Plant & Equip (Net) | $3 | $2 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $57 | $10 | $11 | $21 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $4 | $0 | $0 |
| Total NC Assets | $63 | $16 | $12 | $22 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $162 | $148 | $155 | $165 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $5 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $4 | $3 | $0 |
| Deferred Revenue | $1 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $1 | $0 |
| Total Curr. Liab. | $4 | $5 | $6 | $5 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $4 | $2 | $4 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $4 |
| Total NC Liab. | $4 | $2 | $4 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $0 |
| Total Liabilities | $8 | $8 | $10 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$171 | -$184 | -$177 | -$166 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $325 | $325 | $645 | $322 |
| Total Equity | $155 | $141 | $146 | $156 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$1 | -$1 | -$1 |
| Total Liab. & Tot. Equity | $162 | $148 | $155 | $165 |
| Net Debt | -$15 | -$74 | -$54 | -$42 |